Flat ₹100 OFF on First app order | Use Code: APP100 |
Flat ₹100 OFF
on First app order
Use Code
APP100
Download Now
We recommend Posanat instead of Posahit. Exact salt composition from top brand
100% Same
Salt CompositionEffectivenessStrength
Top Branded
Substitute
Salt Composition in bothPosaconazole 300mg
Salt CompositionPosaconazole 300mg (same for both)
Posahit 300mg Injection 16.7ml
You Searched
Posahit 300mg Injection 16.7ml
Sun Pharmaceutical Industries Ltd.
Posahit 300mg Injection 16.7ml
Sun Pharmaceutical Industries Ltd.
₹6,690.6
Our Recommendation
Posanat 300mg Injection 1s
Natco Pharma Ltd.
52+ Customers trust this
WHO GMP Certified
Assured by
Assured
Posanat 300mg Injection 1s
Assured by
Assured
52+ trust this
WHO GMP Certified
Customers also bought
More About Posahit
Benefits
In Severe fungal infections Posahit 300mg Injection is an antifungal medicine. It works by killing and stopping the growth of fungus that is causing the infection. It helps treat severe infections in severely immunocompromised patients, cancer patients, and those undergoing blood transfusion. It is given as an injection by your doctor or healthcare provider and should not be self-administered. The dose and duration of treatment will depend on what you are being treated for. Make sure you complete the full course of treatment. This will ensure that the infection is completely cured and prevent it from returning.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Your doctor or nurse will give you this medicine. Kindly do not self administer.
How it works
Posahit 300mg Injection is an antifungal medication. It kills fungi by destroying the fungal cell membrane. This treats your infection.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Posahit 300mg Injection . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Seek medical advice from your doctor: Posahit 300mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Seek medical advice from your doctor: Posahit 300mg Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Not Safe: Posahit 300mg Injection may cause side effects which could affect your ability to drive. As you may feel dizzy, sleepy, or have blurred vision while taking Posahit 300mg Injection, which may affect your ability to drive.
Caution Advised: Posahit 300mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Posahit 300mg Injection may be needed. Doctor consultation is advised. Regular monitoring of kidney function tests is advised while taking this medicine. Use of Posahit 300mg Injection is not recommended in patients with moderate to severe kidney disease.
Safe when prescribed by an expert: Posahit 300mg Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Posahit 300mg Injection may not be needed in these patients. Doctor consultation is advised.
What if I forget to take it?
If a dose of Posahit 300mg Injection is missed, it's advisable to consult your doctor.
Manufacturer Address
Plot no 107/108,Namli block , Ranipool, East Sikkim 737135
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
